The effect of the sodium-glucose cotransporter-2 inhibitors in combination with metformin on various metabolic health parameters of patients with type 2 diabetes and visceral obesity

Autor:	A.V. Zhigareva, E.Yu. Pashkova, Kh.Kh. Sharafetdinov, A.S. Ametov
Rok vydání:	2020
Předmět:	medicine.medical_specialty Endocrinology business.industry Internal medicine Sodium/Glucose Cotransporter 2 medicine Type 2 diabetes medicine.disease business Visceral Obesity Metformin medicine.drug Metabolic health
Zdroj:	Endocrinology: News, Opinions, Training. 9:14-20
ISSN:	2658-7416 2304-9529
DOI:	10.33029/2304-9529-2020-9-3-14-20
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::c0b97f4db9fb2b539c4dcfde7a9514a8 https://doi.org/10.33029/2304-9529-2020-9-3-14-20 Zobrazit plný text záznamu